Search Results 691-700 of 16362 for Ureaplasma urealyticum

  1. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Infection requiring systemic antibiotic therapy within 14 days preceding the first dose of study drug, or other severe infection; Inability to swallow orally ...

  2. Asthma - Symptoms and causes - Mayo Clinic

    Find out what can trigger asthma and how to relieve your symptoms and breathe easier.

  3. Continuous Glucose Monitor (CGM) Use in COVID-19 Patients - Mayo Clinic

    Patient with recent positive SARS-COV2 infection and still positive PCR admitted of non-respiratory diagnoses. Diagnosis of diabetes mellitus type 1 or type ...

  4. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

    Any major episode of infection requiring hospitalization or treatment with IV antibiotics within 4 weeks of screening or oral antibiotics within 2 weeks prior ...

  5. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  6. Mosunetuzumab-axgb (intravenous route) - Mayo Clinic

    This medicine may cause serious infections (eg, pneumonia, sepsis, upper respiratory tract infection). Check with your doctor right away if you have chest pain ...

  7. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

    History of an infection requiring intravenous antimicrobial therapy within 1 month or oral antimicrobial therapy within 2 weeks ... Chronic or active hepatitis B ...

  8. Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas - Mayo Clinic

    Uncontrolled inter-current illness including, but not limited to, ongoing or active infection, current pneumonitis, symptomatic congestive heart failure ...

  9. Safety of Regional Citrate Anticoagulation Delivered by the Multifiltratepro System in Continuous Renal Replacement Therapy - Mayo Clinic

    Subjects with active COVID-19 infection. Subject cannot tolerate citrate therapy defined as severe liver disease (see exclusion criteria #3), shock with ...

  10. Skin cancer - Doctors and departments - Mayo Clinic

    Learn about skin cancer, including basal cell carcinoma, melanoma and squamous cell carcinoma. Find out about symptoms, treatments and ways to lower your ...